Ertl G, Wichmann J, Steinke E, Lochner W
Basic Res Cardiol. 1979 Sep-Oct;74(5):456-66. doi: 10.1007/BF01907640.
In order to obtain an estimate of the range of alpha-adrenergic resistance regulation in the coronary vascular system, the following studies were performed: in 15 anesthetized dogs the circumflex coronary artery was cannulated and perfused with above-normal constant pressure to that coronary venous oxygen tension never fell below 40 mmHg. Thus, it was possible to eliminate the influence of the metabolic factor regulating coronary resistance. Furthermore, 15 isolated isovolumetrically working guinea-pig hearts were perfused according to the Langendorff method. Stimulation, resp. blockade, of alpha-receptors was achieved by administering xylometazoline, resp. phentolamine. Xylometazoline increased coronary resistance in both the isolated and the in-situ heart. Administering maximum doses to the anesthetized dog led to an increase in resistance to about 200%. This is equivalent to a reduction of conductance to about 50%. Phentolamine produced no significant effects in the isolated heart. Maximum dosage administered to the heart in situ led to a resistance decrease to about 60%, equivalent to an elevation of conductance to about 170%. If we let control values of coronary resistance and conductance be equal to 100%, our experiments showed alpha-adrenergic regulation of coronary resistance to range from about 60% to 200% and conductance to range from about 50% to 170%.
为了评估冠状动脉系统中α-肾上腺素能阻力调节的范围,进行了以下研究:在15只麻醉犬中,将左旋冠状动脉插管并用高于正常的恒定压力灌注,以使冠状静脉血氧张力从不低于40mmHg。因此,可以消除调节冠状动脉阻力的代谢因素的影响。此外,按照Langendorff方法对15个离体等容工作的豚鼠心脏进行灌注。通过给予赛洛唑啉(分别为酚妥拉明)来实现α受体的刺激(分别为阻断)。赛洛唑啉使离体心脏和原位心脏的冠状动脉阻力均增加。对麻醉犬给予最大剂量导致阻力增加至约200%。这相当于传导率降低至约50%。酚妥拉明在离体心脏中未产生显著影响。对原位心脏给予最大剂量导致阻力降低至约60%,相当于传导率升高至约170%。如果我们将冠状动脉阻力和传导率的对照值设为100%,我们的实验表明α-肾上腺素能对冠状动脉阻力的调节范围约为60%至200%,传导率的调节范围约为50%至170%。